[1] George MG, Tong X, Sonnenfeld N, et al. Recommended use of aspirin and other antiplatelet medications among adults- National Ambulatory Mmedical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008[J]. MMWR Morb Mortal Wkly Rep, 2012, 61 Suppl:11-18.
[2] Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association[J]. Stroke, 2011, 42(1):227-276.
[3] Medeiros FB, de Andrade AC, Angelis GA, et al. Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study[J]. J Oral Maxillofac Surg, 2011, 69(12):2949-2955.
[4] Pototsli M, Amenabar JM. Dental management of patients receiving anticoagulation or antiplatelet treatment[J]. J Oral Sci, 2007, 49(4):253-258.
[5] Ugurlucan M, Caqlar IM, Caqlar FN, et al. Aspirin: from a historical perspective[J]. Recent Pat Cardiovasc Drug Discov, 2012, 7(1):71-76.
[6] Hall R, Mazer CD. Antiplatelet drugs: A review of their pharmacology and management in the perioperative period[J]. Anesth Analg, 2011, 112(2):292-318.
[7] Harrison P, Frelinger AL 3rd, Furman OI, et al. Measuring antiplatelet drug effects in the laboratory[J]. Thromb Res, 2007, 120(3):323-336.
[8] Antithrombotic Trialists’(ATT) Collaboration, Baiqent C, Blackwell C, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials[J]. Lancet, 2009, 373(9678):1849-1860.
[9] Fox KA, Metha SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial[J]. Circulation, 2004, 110(10):1202-1208.
[10] Bednar F, Tencer T, Plasil P, et al. Evaluation of aspirin's effect on platelet function early after coronary artery bypass grafting[J]. J Cardiothorac Vasc Anesth, 2012, 26(4):575-580.
[11] Gukop P, Kakouros N, Hosseini MT, et al. Practice considerations of early aspirin administration following coronary artery bypass surgery[J]. Heart Surg Forum, 2011, 14(1):E7-E11.
[12] Corn M, Jackson DP， Conley CL. Components of blood necessary for clot retraction[J]. Bull Johns Hopkins Hosp, 1960, 107:90-104.
[13] Lockhart PB, Gibson J, Pond SH, et al. Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease[J]. Br Dent J, 2003, 195(8): 439-445.
[14] Madan GA, Madan SG, Mandan G, et al. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients[J]. J Oral Maxillofac Surg, 2005, 63(9): 1262-1265.
[15] Owens CD, Belkin M. Thrombosis and coagulation: operative management of the anticoagulated patient[J]. Surg Clin North Am, 2005, 85(6):1179-1189.
[16] 张伟. 牙及牙槽外科[M]//邱蔚六. 口腔颌面外科学. 6版. 北京：人民卫生出版社，2008：58-59.
[17] 王淑革. 抗栓类药物对口腔颌面部手术和拔牙的影响[J]. 中国城乡企业卫生，2001,(4) ：50-52.
[18] Jimenez AH, Stubbs ME, Tofler GH. Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men[J]. Am J Cardiol, 1992,69(3):258-262.
[19] Gerstein NS, Schulman PM, Gerstein WH, et al. Should more patients continue aspirin therapy preoperatively： Clinical impact of aspirin withdrawal syndrome[J]. Ann Surg, 2012, 255(5):811-819.
[20] Lordkipanidze M, Diodati JG, Pharand C. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence[J]. Parmacol Ther, 2009, 123(2):178-186.
[21] Biondi-Zoccai GG, Lotrionte M, Aqostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50279 patients at risk for coronary artery disease[J]. Eur Heart J, 2006, 27(22): 2667-2674.
[22] Maulaz AB, Bezerra DC, Michel P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke[J]. Arch Neurol, 2005, 62(8): 1217-1220.
[23] Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention- cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis [J]. J Intern Med, 2005, 257(5):399-414.
[24] Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study[J]. Lancet, 2007, 369(9562): 667-678.
[25] Ardekian L, Gaspar R, Peled M, et al. Does low-dose aspirin therapy complicate oral surgical procedure[J]? J Am Dent Assoc, 2000,131(3): 331-335.
[26] Bernnan MT, Valerin MA, Noll JL, et al. Aspirin use and post operative bleeding from dental extractions[J]. J Dent Res, 2008, 87(8):740-744.
[27] Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl):299S-339S. |